Premium
Retrolental Fibroplasia and Treatment with Oxygen
Author(s) -
AALDE OLE,
IMERSLUND OLGA
Publication year - 1954
Publication title -
acta pædiatrica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.772
H-Index - 115
eISSN - 1651-2227
pISSN - 0803-5253
DOI - 10.1111/j.1651-2227.1954.tb04064.x
Subject(s) - medicine , etiology , pediatrics , oxygen therapy , incidence (geometry) , surgery , optics , physics
Summary and Conclusion Among 88 out of 100 surviving prematures with a birth weight of less than 2,000 g treated in the University Pediatric Clinic, Oslo, 1950–1953, 11 cases of retrolental fibroplasia were found, a total incidence of 13 per cent. Out of these 11 cases, 5 presented slight changes which left inconsiderable or slight residua, probably with no damage of vision; 4 presented severe changes which will probably affect the vision; and 2 became blind. No case of retrolental fibroplasia was seen among the prematures who had not been treated with oxygen. In 70 oxygen‐treated prematures, including 11 cases of retrolental fibroplasia, no relationship was found between the duration of oxygen treatment and the occurrence of retrolental fibroplasia except that no case of retrolental fibroplasia was seen when the duration of oxygen treatment was less than 14 days. The results of these examinations may suggest that treatment with oxygen is not the only etiological factor responsible for retrolental fibroplasia, for most of the prematures treated with oxygen did not develop the disease.